Search
for
Sort by
Research 31–60 of 437
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders
- PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
- Hair metal dysregulation in Parkinson’s disease: Implications for diagnosis and gut-brain axis involvement
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Hormesis and medicine
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Adverse health effects of androgen use
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Hair glucocorticoid levels in Parkinson’s disease
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Phytochemicals and Nano-Phytopharmaceuticals Use in Skin, Urogenital and Locomotor Disorders: Are We There?
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- Advances in mitochondria-centered mechanism behind the roles of androgens and androgen receptor in the regulation of glucose and lipid metabolism
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Cardiometabolic profile of young women with hypoprolactinemia
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- The compatibility of Bacillus thuringiensis Cry protein-solubilizing buffers with the droplet feeding method in fall armyworm larvae
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors